Sanli UA - Search Results

1

Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.

Kucukzeybek Y, Gorumlu G, Karaca B, Erten C, Cengiz E, Kemal Gul M, Karabulut B, Uslu R, Sanli UA, Goker E. Kucukzeybek Y, et al. Among authors: sanli ua. J BUON. 2008 Apr-Jun;13(2):199-203. J BUON. 2008. PMID: 18555465

2

Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.

Uslu R, Sanli UA, Sezgin C, Karabulut B, Terzioglu E, Omay SB, Goker E. Uslu R, et al. Among authors: sanli ua. Clin Cancer Res. 2000 Dec;6(12):4957-64. Clin Cancer Res. 2000. PMID: 11156257

3

Which dosing scheme is suitable for the taxanes? An in vitro model.

Sanli UA, Uslu R, Karabulut B, Sezgin C, Saydam G, Omay SB, Goker E. Sanli UA, et al. Arch Pharm Res. 2002 Aug;25(4):550-5. doi: 10.1007/BF02976617. Arch Pharm Res. 2002. PMID: 12214871

4

Bioembolisation for unresectable hepatocellular carcinoma: preliminary results of a translational research study.

Goker E, Sanli UA, Yuzer Y, Uslu R, Karabulut B, Memis A, Coker A, Mentes A. Goker E, et al. Among authors: sanli ua. J Exp Clin Cancer Res. 2004 Sep;23(3):403-9. J Exp Clin Cancer Res. 2004. PMID: 15595628 Clinical Trial.

5

Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens.

Uslu R, Sanli UA, Dikmen Y, Karabulut B, Ozsaran A, Sezgin C, Muezzinoglu GG, Omay SB, Goker E. Uslu R, et al. Among authors: sanli ua. Int J Gynecol Cancer. 2005 Mar-Apr;15(2):240-5. doi: 10.1111/j.1525-1438.2005.15210.x. Int J Gynecol Cancer. 2005. PMID: 15823106 Free article. Clinical Trial.

6

Potential predictive factors for response to weekly paclitaxel treatment in patients with metastatic breast cancer.

Sezgin C, Karabulut B, Uslu R, Sanli UA, Goksel G, Zekioglu O, Ozdemir N, Goker E. Sezgin C, et al. Among authors: sanli ua. J Chemother. 2005 Feb;17(1):96-103. doi: 10.1179/joc.2005.17.1.96. J Chemother. 2005. PMID: 15828451

7

Topotecan in platinum-resistant epithelial ovarian cancer.

Karabulut B, Sezgin C, Terek MC, Uslu R, Sanli UA, Akman L, Ozsaran A, Dikmen Y, Goker E. Karabulut B, et al. Among authors: sanli ua. Chemotherapy. 2005 Oct;51(6):347-51. doi: 10.1159/000088959. Epub 2005 Oct 14. Chemotherapy. 2005. PMID: 16227688

8

Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors.

Sezgin C, Karabulut B, Uslu R, Sanli UA, Goksel G, Yuzer Y, Goker E. Sezgin C, et al. Among authors: sanli ua. Scand J Gastroenterol. 2005 Dec;40(12):1486-92. doi: 10.1080/00365520510023819. Scand J Gastroenterol. 2005. PMID: 16293561

9

Single-agent irinotecan for recurrent/metastatic colorectal cancer: a retrospective analysis.

Sanli UA, Karabulut B, Uslu R, Korkut M, Goker E. Sanli UA, et al. Med Princ Pract. 2006;15(4):288-92. doi: 10.1159/000092992. Med Princ Pract. 2006. PMID: 16763396 Free article.

10

Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity.

Askar N, Cirpan T, Toprak E, Karabulut B, Selvi N, Terek MC, Uslu R, Sanli UA, Goker E. Askar N, et al. Among authors: sanli ua. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1552-6. doi: 10.1111/j.1525-1438.2006.00626.x. Int J Gynecol Cancer. 2006. PMID: 16884364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters